<DOC>
	<DOC>NCT01067898</DOC>
	<brief_summary>The purpose of this study is to determine if infrequent administration of oral vitamin D megadoses is effective treatment to maintain serum 25-hydroxyvitamin D(3) above target levels of 50-75 nmol/L. The investigators hypothesize that 100 000 IU or at least 200 000 IU vitamin D3 in every three months would be effective and safe treatment to achieve the target levels.</brief_summary>
	<brief_title>A Study on Oral Vitamin D Megadoses</brief_title>
	<detailed_description />
	<mesh_term>Avitaminosis</mesh_term>
	<mesh_term>Rickets</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Calcium Carbonate</mesh_term>
	<criteria>female 7080 yrs old disease or medication affecting calcium homeostasis renal failure (PtGFReCG &lt; 35 ml/min)</criteria>
	<gender>Female</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>vitamin D supplementation</keyword>
	<keyword>cholecalciferol</keyword>
	<keyword>PTH</keyword>
	<keyword>bone turnover markers</keyword>
	<keyword>elderly women</keyword>
</DOC>